Oncogene, 0950-9232

Journal

1 - 50 out of 102Page size: 50
Sort by: Type

Publications

  1. Article › Research › Not peer-reviewed
  2. Published

    A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients

    Padma-Sheela Jayaraman, 28 Oct 2010, In: Oncogene. 29, 43, p. 5796-5808 13 p.

    Research output: Contribution to journal › Article

  3. Published

    A role for iron in Wnt signalling

    Matthew Brookes, Neil Hotchin, Glenn Matthews, Tariq Iqbal & Chris Tselepis, 7 Feb 2008, In: Oncogene. 27, 7, p. 966-75 10 p.

    Research output: Contribution to journal › Article

  4. Published

    Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5

    Peter Cockerill, Maarten Hoogenkamp, Conny Bonifer, 20 May 2010, In: Oncogene. 29, 20, p. 2927-37 11 p.

    Research output: Contribution to journal › Article

  5. Published

    Abnormal expression of 11beta-HSD type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation

    Elizabeth Rabbitt, John Ayuk, Kristien Boelaert, Michael Sheppard, Martin Hewison, Paul Stewart & Neil Gittoes, 20 Mar 2003, In: Oncogene. 22(11), 11, p. 1663-1667 5 p.

    Research output: Contribution to journal › Article

  6. Published

    Adenovirus 5 E1A is responsible for increased expression of insulin receptor substrate 4 in established adenovirus 5-transformed cell lines and interacts with IRS components activating the PI3 kinase/Akt signalling pathway.

    Neil Shimwell, Ashley Martin, Rachel Bruton, Garry Sedgwick, Phil Gallimore, Andrew Turnell & Roger Grand, 5 Feb 2009, In: Oncogene. 28, 5, p. 686-97 12 p.

    Research output: Contribution to journal › Article

  7. Published

    Adenovirus E1A: Remodelling the host cell, a life or death experience

    Phil Gallimore & Andrew Turnell, 26 Nov 2001, In: Oncogene. 20, 54, p. 7824-7835 12 p.

    Research output: Contribution to journal › Article

  8. Published

    Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth

    Roy Bicknell, 24 May 2001, In: Oncogene. 20, 23, p. 2937-45 9 p.

    Research output: Contribution to journal › Article

  9. Published

    Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis

    Roy Bicknell, 25 Apr 2002, In: Oncogene. 21, 18, p. 2815-21 7 p.

    Research output: Contribution to journal › Article

  10. Published

    Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells

    Farhat Khanim, Victoria Wood, Laura O'Neill, Paul Stewart, Bryan Turner & Moray Campbell, 9 Aug 2004, In: Oncogene. 23, p. 6712-25 14 p.

    Research output: Contribution to journal › Article

  11. Published

    An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells

    John Heath, 17 Jan 2002, In: Oncogene. 21, 3, p. 460-474 15 p.

    Research output: Contribution to journal › Article

  12. Published

    Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A2 and 5-lipoxygenase catalysed pathway

    Richard Woodfield, Matthew Hodgkin, Trevor Pettitt, Ashley Martin, David Kerr & Mike Wakelam, 22 Aug 2002, In: Oncogene. 21, 37, p. 5765-5772 8 p.

    Research output: Contribution to journal › Article

  13. Published

    C-terminal binding protein interacting protein (CtIP) binds directly to adenovirus early region 1A through its N-terminal region and conserved region 3

    Rachel Bruton, Nikki Young, David Onion, Andrew Turnell & Roger Grand, 4 Jun 2007, In: Oncogene. 26, p. 7467-7479 13 p.

    Research output: Contribution to journal › Article

  14. Published

    Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene

    Farida Latif, 17 Jun 1998, In: Oncogene. 16, 24, p. 3151-3157 7 p.

    Research output: Contribution to journal › Article

  15. Published

    Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth

    Christopher Dawson, Suzanne Stewart, John Gordon, Paul Murray, Lawrence Young & Aris Eliopoulos, 8 Aug 2005, In: Oncogene. 24, p. 7913-7923 11 p.

    Research output: Contribution to journal › Article

  16. Published

    Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer

    Timothy Porter, Frances Richards, John Jankowski, Reading Payne & Eamonn Maher, 14 Mar 2002, In: Oncogene. 21, 12, p. 1928-1933 6 p.

    Research output: Contribution to journal › Article

  17. Published

    CpG island promotor hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations

    Luke Hesson, Richard Wilson, Dion Morton, Michael Walker, Eamonn Maher & Farida Latif, 4 Apr 2005, In: Oncogene. 24, p. 3987-3994 8 p.

    Research output: Contribution to journal › Article

  18. Published

    Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients

    Angelo Agathanggelou, Eamonn Maher & Farida Latif, 9 Jan 2003, In: Oncogene. 22, 1, p. 147-150 4 p.

    Research output: Contribution to journal › Article

  19. Published

    Dissociation of caspase mediated events and programmed cell death induced via HLA-DR in Follicular Lymphoma

    Janet Lord, Janet Lord, 21 Nov 2005, In: Oncogene. 25, p. 1914-21 8 p.

    Research output: Contribution to journal › Article

  20. Published

    Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.

    Nick Underhill-Day, Eamonn Maher & Farida Latif, 18 Oct 2010, In: Oncogene. 30, 8, p. 978-989 13 p.

    Research output: Contribution to journal › Article

  21. Published

    Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers

    Angelo Agathanggelou, Ashraf Dallol, Eamonn Maher & Farida Latif, 13 Mar 2003, In: Oncogene. 22, 10, p. 1580-1588 9 p.

    Research output: Contribution to journal › Article

  22. Published

    Epstein-Barr virus and oncogenesis: From latent genes to tumours

    Lawrence Young & Paul Murray, 11 Aug 2003, In: Oncogene. 22, 33, p. 5108-5121 14 p.

    Research output: Contribution to journal › Article

  23. Published

    Epstein-Barr virus latent membrane protein 1 (LMP1) up-regulates Id1 expression in nasopharyngeal epithelial cells

    Aris Eliopoulos, Lawrence Young, 5 Apr 2004, In: Oncogene. 23, p. 4488-4494 7 p.

    Research output: Contribution to journal › Article

  24. Published

    Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFβ signaling pathways

    Victoria Wood, John O'Neil, Wenbin Wei, Suzanne Stewart, Christopher Dawson & Lawrence Young, 7 May 2007, In: Oncogene. 26, p. 4135-4147 13 p.

    Research output: Contribution to journal › Article

  25. Published

    Evaluation of the 3p21.3 tumour-suppresor gene cluster

    Luke Hesson, Wendy Cooper & Farida Latif, 28 May 2007, In: Oncogene. 26, 52, p. 7283-7301 19 p.

    Research output: Contribution to journal › Article

  26. Published

    Expression of HIF-1alpha, HIF-2alpha (EPAS1) and their target genes in paraganglioma and phaeochromocytoma with VHL and SDH mutations

    Farida Latif & Eamonn Maher, 5 Sep 2006, In: Oncogene. 91, p. 4593-4598 6 p.

    Research output: Contribution to journal › Article

  27. Published

    Frequent RASSAF1A tumour suppresor gene promotor methylation in Wilms tumour and colorectal cancer

    Kate Wagner, Wendy Cooper, Richard Grundy, Germaine Caldwell, Roy Wadey, Dion Morton, Farida Latif & Eamonn Maher, 17 Oct 2002, In: Oncogene. 21, 47, p. 7277-7282 6 p.

    Research output: Contribution to journal › Article

  28. Published

    Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas

    Luke Hesson, Eamonn Maher & Farida Latif, 26 Jan 2004, In: Oncogene. 23, p. 2408-2419 12 p.

    Research output: Contribution to journal › Article

  29. Published

    Frequent epigenetic inactivation of the RASSF1A tumor suppresor gene in Hodgkin's lymphoma

    Paul Murray, Angelo Agathanggelou, Farida Latif, Richard Grundy, Lawrence Young, 1 Jan 2004, In: Oncogene. 23, 6, p. 1326-1331 6 p.

    Research output: Contribution to journal › Article

  30. Published

    Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in testicular tumours and distinct methylation profiles in seminoma and non-seminoma testicular germ cell tumours

    Eamonn Maher & Farida Latif, 23 Jan 2003, In: Oncogene. 22, 3, p. 461-466 6 p.

    Research output: Contribution to journal › Article

  31. Published

    Frequent epigenetic inactivation of the SLIT2 gene in gliomas

    Ashraf Dallol, Eamonn Maher & Farida Latif, 17 Jul 2003, In: Oncogene. 22, 29, p. 4611-4616 6 p.

    Research output: Contribution to journal › Article

  32. Published

    Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumour suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

    Paul Murray, 10 Oct 2005, In: Oncogene. 25, p. 1070-1080 11 p.

    Research output: Contribution to journal › Article

  33. Published

    Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization

    Michael Griffiths, 21 Jun 2007, In: Oncogene. 26, 29, p. 4306-4318 13 p.

    Research output: Contribution to journal › Article

  34. Published

    Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.

    Mark Morris, Christopher Ricketts, Fiona McRonald, Farida Latif & Eamonn Maher, 24 Mar 2011, In: Oncogene. 30, 12, p. 1390-401 12 p.

    Research output: Contribution to journal › Article

  35. Published

    Genomic characterisation of the chromosomal breakpoints of the t(4;14) of multiple myeloma suggest more than one possible aetiological mechanism

    Dickens Pratt, 20 Feb 2003, In: Oncogene. 22, 7, p. 1103-1113 11 p.

    Research output: Contribution to journal › Article

  36. Published

    Homozygous deletions at 3p12 in breast and lung cancer

    Jie Xiong, Farida Latif, 1 Oct 1998, In: Oncogene. 17, 13, p. 1723-9 7 p.

    Research output: Contribution to journal › Article

  37. Published

    Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma

    Mark Morris, Christopher Ricketts, Farida Latif & Eamonn Maher, 1 Apr 2010, In: Oncogene. 29, 14, p. 2104-2117 14 p.

    Research output: Contribution to journal › Article

  38. Published

    Identification of novel VHL target genes and relationship to hypoxic response pathways

    Esther Maina, Mark Morris & Malgosia Zatyka, 11 Apr 2005, In: Oncogene. 24, p. 4549-4558 10 p.

    Research output: Contribution to journal › Article

  39. Published

    Identification of novel VHL targets that are associated with the development of renal cell carcinoma

    Esther Maina, Mark Morris, Malgosia Zatyka, Farida Latif & Eamonn Maher, 8 Mar 2007, In: Oncogene. 26, 11, p. 1661-72 12 p.

    Research output: Contribution to journal › Article

  40. Published

    Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

    Angelo Agathanggelou, Donia MaCartney, Ashraf Dallol, Paul Fullwood, Eamonn Maher & Farida Latif, 22 Mar 2001, In: Oncogene. 20, 12, p. 1509-1518 10 p.

    Research output: Contribution to journal › Article

  41. Published

    Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma

    Mark Morris, Kate Wagner, Neil Morgan, Dewi Astuti, Robert Lees, Wendy Cooper, Richard Grundy, Farida Latif & Eamonn Maher, 2 Oct 2003, In: Oncogene. 22, 43, p. 6794-6801 8 p.

    Research output: Contribution to journal › Article

  42. Published

    NORE1A, a homologue of RASSF1A tumor suppressor gene is inactivated in human cancers

    Ashraf Dallol, Eamonn Maher & Farida Latif, 13 Feb 2003, In: Oncogene. 22, 6, p. 947-954 8 p.

    Research output: Contribution to journal › Article

  43. Published

    PTTG and PBF repress the human sodium iodide symporter

    Kristien Boelaert, Vicki Smith, Lesley Tannahill, Margaret Eggo, Jayne Franklyn & Christopher McCabe, 5 Feb 2007, In: Oncogene. 26, 30, p. 4344-4356 13 p.

    Research output: Contribution to journal › Article

  44. Published

    Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells

    Martin Rowe, 14 Feb 2002, In: Oncogene. 21, p. 1263-1271 9 p.

    Research output: Contribution to journal › Article

  45. Published

    Pituitary Tumor Transforming Gene (PTTG) Induces Genetic Instability in Thyroid Cells

    Dae Kim, Kristien Boelaert, Victor Lopes, Jayne Franklyn & Christopher McCabe, 9 May 2005, In: Oncogene. 24(30), p. 4861-4866 6 p.

    Research output: Contribution to journal › Article

  46. Published

    Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo

    Louise Hiller, 12 Apr 2004, In: Oncogene. 23, p. 3328-3337 10 p.

    Research output: Contribution to journal › Article

  47. Published

    Professor Alan M Gewirtz (1949-2010) OBITUARY

    Jon Frampton, 1 May 2011, In: Oncogene. 30, 19, p. 2187-2187 1 p.

    Research output: Contribution to journal › Article

  48. Published

    RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastomas

    Dewi Astuti, Angelo Agathanggelou, Ashraf Dallol, Carole Cummins, Farida Latif & Eamonn Maher, 8 Nov 2001, In: Oncogene. 20, 51, p. 7573-7577 5 p.

    Research output: Contribution to journal › Article

  49. Published

    RASSF2 associates with and stabilizes the proapoptotic kinase MST2.

    Ashraf Dallol & Farida Latif, 15 Jun 2009, In: Oncogene. 28, 33, p. 2988-2998 11 p.

    Research output: Contribution to journal › Article

  50. Published

    RASSF6 is a novel member of the RASSF family of tumor suppressors

    Luke Hesson, Farida Latif, 1 Sep 2007, In: Oncogene. 26, 42, p. 6203-6211 9 p.

    Research output: Contribution to journal › Article

  51. Published

    Synergistic growth inhibition of prostate cancer cells by 1α,25 Dihydroxyvitamin D3 and its 19-nor-hexafluoride analgos incombination with either sodium butyrate or trichostatin A

    Jasbir Moore, Philip Driver, Jacqueline Engel, Geoff Brown & Moray Campbell, 5 Apr 2001, In: Oncogene. 20, 15, p. 1860-1872 13 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 Next